A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
ID Number 09-0598Principal Investigator(s)
Samin K Sharma
Department(s) or Division(s)
The Zena and Michael A. Wiener Cardiovascular Institute
The purpose of this study is to see if the XIENCE PRIME stent is a safe and effective treatment for the narrowing of heart arteries. This trial will use the drug-coated stents named the XIENCE PRIME and XIENCE PRIME LL Everolimus Eluting Coronary Stent System, which will be called the XIENCE PRIME stent or XIENCE PRIME stent system. The XIENCE PRIME stent system is made of a metal mesh tube made of cobalt and chromium coated with two plastic-like (polymer) layers which contain a drug and an expandable balloon used to deliver the stent to the narrowed area of the heart artery.
Recruiting Patients: No